Purchases and Sales Made in Q4 2022 in In Med Pharmaceuticals Inc. (INM)
This table provides information about the institutional ownership of In Med Pharmaceuticals Inc. (INM) during Q4 2022. The information is specifically focused on institutions that hold shares of InMed Pharmaceuticals Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 15, 2023
Q4 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
17.7KNew |
$23.4K - $141K
|
17.7K
$4.25K
|
|
|
Feb 14, 2023
Q4 2022
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
7.16K+ 7.96% |
$9.46K - $56.9K
|
97.2K
$23.3K
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
50New |
$66 - $398
|
50
$12
|
|
|
Feb 13, 2023
Q4 2022
|
Advisory Services Network, LLC
|
BUY
|
- |
6New |
$7.92 - $47.7
|
6
$1.44
|
|
|
Feb 14, 2023
Q4 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
2+ 22.22% |
$2.64 - $15.9
|
11
$2.64
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 10, 2023
Q4 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-2- 2.63% |
$2.64 - $15.9
|
74
$17.8
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-133- 99.25% |
$176 - $1.06K
|
1
$0.24
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-4.97K- 85.66% |
$6.56K - $39.5K
|
831
$199
|